Business, energy, technology, markets and global industry news from Business News Today

lysergide tartrate

PharmaDeviceNews lysergide tartrate
Representative image: Definium Therapeutics’ DT120 ODT Phase 3 Emerge study highlights the growing focus on psychedelic psychiatry and new treatment approaches for major depressive disorder.
Pharma & Biotech

Definium Therapeutics nears pivotal MDD test as DT120 ODT faces Phase 3 scrutiny

Find out how Definium Therapeutics’ DT120 ODT Phase 3 MDD readout could reshape psychedelic psychiatry and depression drug development.

Read More
Pharma & Biotech

Is lysergide finally going mainstream? Definium Therapeutics bets on DT120 ODT clinical momentum

Can DT120 ODT transform mental health treatment? Explore Definium Therapeutics’ pivotal trials and what they mean for psychedelic psychiatry.

Read More